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ABSTRACT
TRAP is an 11 subunit RNA binding protein that
regulates expression of genes involved in trypto-
phan biosynthesis and transport in Bacillus subtilis.
TRAP is activated to bind RNA by binding up to
11 molecules of L-tryptophan in pockets formed by
adjacent subunits. The precise mechanism by which
tryptophan binding activates TRAP is not known.
Thr30 is in the tryptophan binding pocket. A TRAP
mutant in which Thr30 is substituted with Val (T30V)
does not bind tryptophan but binds RNA con-
stitutively, suggesting that Thr30 plays a key role
in the activation mechanism. We have examined
the effects of other substitutions of Thr30. TRAP
proteins with small b-branched aliphatic side
chains at residue 30 bind RNA constitutively,
whereas those with a small polar side chain show
tryptophan-dependent RNA binding. Several mutant
proteins exhibited constitutive RNA binding that
was enhanced by tryptophan. Although the try-
ptophan and RNA binding sites on TRAP are
distinct and are separated by  7.5 A ˚, several sub-
stitutions of residues that interact with the bound
RNA restored tryptophan binding to T30V TRAP.
These observations support the hypothesis that
conformational changes in TRAP relay information
between the tryptophan and RNA binding sites of
the protein.
INTRODUCTION
In Bacillus subtilis, genes involved in tryptophan biosynthesis
and transport are regulated by a tryptophan-activated RNA
binding protein called TRAP (trp RNA binding attenuation
protein) (1,2). TRAP regulates both transcription and trans-
lation of these genes in response to changes in intracellular
levels of L-tryptophan. TRAP is composed of eleven identical
subunits arranged in a symmetric ring (3,4). TRAP is
activated to bind RNA by binding up to 11 molecules of
L-tryptophan in pockets formed by adjacent subunits. The
natural RNA targets of TRAP contain 9–11 NAG (where
N ¼ G   U > A > C) triplet repeats separated by several non-
conserved spacer residues (5–9). As a result of TRAP binding
to several RNA targets, expression of the trp genes is down
regulated. Alternatively, when the tryptophan level is growth
limiting, TRAP is not activated to bind RNA, which allows
elevated expression of the tryptophan synthesis genes.
Several crystal structures of tryptophan-activated TRAP in
complex with RNAs containing 11 GAG or UAG repeats
revealed that the RNA binds by wrapping around the outer
periphery of the protein ring. The bound RNA interacts
primarily with four amino acids of each subunit: Glu36,
Lys37, Lys56 and Arg58 (10–12). These residues as well as
those involved in binding tryptophan (see below), are
completely conserved in all currently available TRAP
sequences, which have 64–86% identity to B.subtilis TRAP
[(3) and P. Gollnick unpublished data].
In comparison to the interaction with RNA, relatively little
is known about the mechanism by which tryptophan binding
activates TRAP to bind RNA. There is currently no high
resolution structure of TRAP in the absence of tryptophan.
TRAP is an 11mer in the absence or presence of tryptophan,
which rules out a mechanism of activation involving altering
oligomerization of the protein (13,14). Although each TRAP
11mer can bind up to 11 molecules of L-tryptophan, studies
of hetero-11mers containing varying ratios of WT and mutant
subunits (defective in tryptophan binding) have shown
that the presence of just one or two bound tryptophans
signiﬁcantly activates TRAP to bind RNA (14). NMR studies
have shown that tryptophan binding alters the dynamic
properties of TRAP. In particular, tryptophan binding
reduces the ﬂexibility of the tryptophan- and RNA-binding
regions of TRAP, which is likely an important feature of
the activation mechanism (15). The observation that apo-
TRAP is quite ﬂexible and contains regions that are
dynamically disordered likely explains why it has not been
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Each bound tryptophan is completely buried in a pocket
between adjacent subunits, and it forms one hydrogen bond
with the side chains of four TRAP residues (4). These include
Thr49 and Thr52 from one subunit and Thr30 and Ser53 from
the adjacent subunit. The interactions with Thr30 and Thr49
have been shown to be essential for activation of TRAP
whereas the hydrogen bond with Ser53 is dispensable (16).
The interaction of Thr52 with tryptophan has only a limited
role in activation of TRAP. In addition, each bound trypto-
phan hydrogen bonds with the main-chain portions of several
TRAP residues, including Thr25, Gly27, Asp29 and Gln47.
Of these, only the interactions with Thr25 and Gln47 have
been shown to play a role in activation (12,16).
The importance of Thr30 in tryptophan binding and activa-
tion of TRAP is demonstrated by the dramatic effects of two
substitutions (Ala and Val) at this position. Substituting Ala
for Thr30 (T30A) disrupts both the tryptophan- and RNA-
binding activities of the protein (16). In contrast, T30V
TRAP, with valine at position 30, does not bind tryptophan,
but binds RNA constitutively, although with  100-fold lower
afﬁnity than tryptophan-activated WT TRAP (16). Character-
ization of the interaction of T30V TRAP with RNA showed
that the mutant protein recognizes similar features of the
RNA as does WT TRAP (17). This observation suggests
that the T30V substitution may activate TRAP in a manner
similar to how tryptophan binding activates WT TRAP.
To provide a better understanding of the role of Thr30 in
activation of TRAP, we introduced several additional sub-
stitutions at position 30 and examined the RNA binding
and tryptophan binding properties of the resulting mutant pro-
teins. We also determined that in general, the same amino
acid residues in WT TRAP and T30V TRAP are important
for RNA binding. However, the side chain of Lys37, which
plays an important role in the WT complex, does not contrib-
ute to the stability of the T30V TRAP–RNA complex.
Additionally, we found that altering residues in T30V
TRAP that contact the RNA affects the tryptophan binding
properties of the resulting double mutant proteins. This ﬁnd-
ing indicates that information can be transferred from the
RNA binding region to the tryptophan binding site even
though these sites are distinct and >7.5 A ˚ apart (11).
MATERIALS AND METHODS
Plasmids and strains
For expression of WT or mutant TRAP, the mtrB gene, which
encodes TRAP, was inserted between the EcoRI and HindIII
sites of pBSKS (Stratagene) to create pBSKSmtrB or between
the NdeI and NotI sites of pET9a (Novagen) to create pET-
mtrB. For in vitro transcription, pTZ18U(GAGTT)11 was
used (18). This plasmid has a 55 nt insert consisting of eleven
tandem GAGTT repeats ligated between the EcoRI and Hin-
dIII restriction sites of pTZ18U (USB). Escherichia coli
strains SG62052 / pGP1-2 (19) and BL21 Rosetta (Novagen)
were used for protein expression and strain K802 was used to
propagate plasmids.
Plasmids pVP5WT and pVP5T30V were used to express
WT TRAP and T30V TRAP, respectively, in B.subtilis
BYC1 {DmtrB argC4 amyE::[Ptrp-trpL-(trpE0-0lacZ)E m
r ]}
for b-galactosidase assays. BYC1 was created by transform-
ing B.subtilis BG4233 (DmtrB argC4) (20) with genomic
DNA of CYBS12 {argC4 amyE::[Ptrp-trpL-(trpE0-0lacZ)
Em
r]} (21). pVP5 was constructed from pHB201 (22) by
inserting a tetracycline resistance cassette obtained from
pDG1513 (23) (Bacillus Genetic Stock Center) at a unique
ClaI site. pVP5WT was constructed by inserting the 30 por-
tion of the mtrA gene and the full-length mtrB gene [809 to
1002, numbering as given by Gollnick et al. (24)] between
the NotI and BamHI restriction sites in pVP5. pVPT30V
was constructed by using the QuikChange Site-Directed
Mutagenesis Kit (Stratagene) to change codon 30 from Thr
to Val (ACA to GTT) using pVP5WT as template.
Site-directed mutagenesis
Two PCR-based site-directed mutagenesis methods were
used to generate genes that encode mutant TRAP proteins.
The ﬁrst method, using four oligonucleotide primers, was
described previously (12). Brieﬂy, using pBSKSmtrAB (12)
as template, two overlapping DNA fragments were generated
in two separate PCR. One reaction contained an oligonuc-
leotide with the desired mutation in mtrB together with the
universal reverse primer. The second PCR contained the
universal  40 primer together with an oligonucleotide that
annealed to positions 1229 to 1251 of the mtr operon
[numbering as in Gollnick et al. (24)]. The two resulting
PCR products were puriﬁed, mixed together, denatured by
boiling, and annealed (by their partial overlap) by slow cool-
ing to room temperature. The single-stranded 50 overhangs
were ﬁlled in using the Klenow enzyme. The resulting prod-
uct was ampliﬁed by PCR using the SK and KS universal pri-
mers to generate a full length mtrB gene with  50% mutant
and 50% wild-type sequences. These PCR products were
digested with EcoRI and HindIII and ligated into similarly
digested pBlueScriptKS( ). Alternatively, some of the mut-
ant mtrB genes used in this study were created using the
QuikChange Site-Directed Mutagenesis Kit (Stratagene)
with pETmtrB as template. In all cases, clones containing
the desired mutations were identiﬁed by DNA sequencing
using Sequenase (USB).
Purification of WT and mutant TRAP
Wild-type TRAP was puriﬁed by phenyl agarose chromato-
graphy (25). Mutant proteins were puriﬁed either by phenyl
agarose chromatography, immunoafﬁnity chromatography
or chromatography on Q-Sepharose as described previously
(5,25). Each protein preparation was examined by SDS–
PAGE and quantiﬁed by the BCA protein assay (Pierce)
using WT TRAP of known concentration as the standard.
b-Galactosidase assays
Assays of b-galactosidase activity were performed as
described previously (21) with B.subtilis cells grown in
minimal medium with 0.2% acid-hydrolyzed casein in the
absence or presence of 50 mg/ml L-tryptophan.
Trypsin cleavage assay
Trypsin cleavage of WT and mutant TRAP proteins was per-
formed as described previously (15). TRAP (37 mM) was
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subunits) tryptophan in 50 mM sodium phosphate (pH 8.0)
with 100 mM NaCl at room temperature for 5 min. Trypsin
(5% w/w) (Sigma) was then added and aliquots were
removed at various times, from 0 to 30 min. The reactions
were stopped by adding an equal volume of 2· SDS gel load-
ing dye and analyzed by 16% Tris–Tricine SDS–PAGE. Gels
were stained with GelCode Blue stain (Pierce). Bands were
quantiﬁed using ImageQuant (Molecular Dynamics) and the
results were plotted as percentage cleavage versus incubation
time with trypsin.
RNA synthesis
32P-labeled RNA for binding assays was prepared by in vitro
transcription of HindIII-linearized pTZ18U(GAGTT)11 with
T7 RNA polymerase in the presence of [a
32P]UTP as
described previously (26). The RNA was gel puriﬁed on
8 M urea/10% polyacrylamide gels and extracted by
a crush and soak procedure (26).
RNA and tryptophan binding assays
RNA binding to TRAP was measured by a nitrocellulose
ﬁlter binding assay described previously (26). Samples con-
taining
32P-labeled (GAGUU)11 RNA (1 · 10
4 d.p.m.) and
increasing amounts of TRAP were incubated at 37 C for
1 h in the absence or presence of 1 mM tryptophan before
ﬁltering. The data were analyzed using a nonlinear least
squares ﬁtting to single binding site equation (7) (Prizm,
Graph-pad Software Inc., San Diego, CA).
Tryptophan binding to TRAP was measured by a ﬂuores-
cence assay based on competition between tryptophan and
ANS (1-anilinonapthalene-8-sulfonic acid) as described pre-
viously (17). TRAP (1 mM) was incubated with 5 mM
ANS, which is weakly ﬂuorescent by itself but ﬂuoresces
strongly at 460 nm (excitation at 372 nm) upon binding to
TRAP. Increasing amounts of tryptophan were then added
and incubated for 1 min, which was found to be adequate
to reach equilibrium. The decrease in ﬂuorescence at 460
nm as a function of tryptophan concentration was determined
and ﬁt to the Hill equation [Prizm, Graph-pad Software Inc.,
San Diego, CA (17)].
RESULTS
T30V TRAP mediated regulation of
the trp operon in vivo
T30V TRAP has been shown to bind trp leader RNA con-
stitutively in vitro although with lower afﬁnity than
tryptophan-activated WT TRAP (16,17). We compared the
ability of WT TRAP and T30V TRAP to regulate a trpE0-
0lacZ translational fusion under control of the trp promoter
and leader region in vivo. This fusion was not regulated in
the absence of TRAP (Table 1). As seen previously (16,21),
b-galactosidase expression was regulated 200-fold in
response to tryptophan in cells containing WT TRAP
(Table 1). The level of expression from this fusion in the
strain lacking TRAP was nearly 10-fold higher than in WT
TRAP containing cells grown in the absence of tryptophan.
This difference likely reﬂects the intracellular levels of
tryptophan present in BYC1, which is trp
+, when these
cells are grown in the absence of exogenous tryptophan. In
contrast to the results with WT TRAP, cells containing
T30V TRAP showed no regulation in response to tryptophan.
However, the presence of T30V TRAP (either in the absence
or presence of tryptophan) reduced b-galactosidase expres-
sion  15-fold as compared to BYC1 without TRAP, and
 2-fold compared that seen for cells with WT TRAP
grown in the absence of tryptophan. These results show that
T30V TRAP down-regulated expression of the fusion but did
not respond to tryptophan. Hence the ability of T30V TRAP
to regulate the trpE0-0lacZ fusion closely parallels its activity
in vitro, i.e. low afﬁnity for RNA that is not affected by the
presence of tryptophan correlates with modest regulation that
does not respond to tryptophan.
Trypsin cleavage of WT and T30V TRAP
Relatively little is known about the mechanism by which
tryptophan binding activates TRAP to bind RNA. The bind-
ing sites for tryptophan and RNA are distinct and the closest
atom of a bound tryptophan is  7.5 A ˚ from the bound RNA
(4). Several studies suggest that tryptophan binding induces
a conformational change in the protein that alters the RNA
binding region (15,27). In particular, NMR studies indicate
that tryptophan binding reduces the conformational ﬂexibility
of the protein in the vicinity of the bound tryptophan and that
these changes in dynamics are propagated to the RNA bind-
ing surface of TRAP (15). These authors also showed that
tryptophan-bound TRAP is resistant to cleavage by trypsin
whereas apo-TRAP (in the absence of tryptophan) is cleaved
after Arg31, which is in close proximity to the tryptophan
binding pocket (15).
Recent studies have shown that T30V TRAP and
tryptophan-activated WT TRAP recognize similar features
of the (G/U)AG RNA repeats, which suggests that these
two proteins may function similarly (17). To test the possib-
ility that the T30V substitution alters the mutant protein so
that it resembles tryptophan activated WT TRAP, we
examined the susceptibility of T30V TRAP to trypsin cleav-
age. As seen previously with Bacillus stearothermophillus
TRAP (15), WT B.subtilis apo-TRAP was much more
susceptible to trypsin cleavage than the TRAP–tryptophan
complex (Figure 1). The migration of the fragments
obtained by trypsin cleavage of both B.subtilis and
B.stearothermophillus TRAP was similar on SDS gels (data
not shown), suggesting that the site of cleavage is the same
(after residue 31) in both proteins.




 Trp +Trp ( Trp/+Trp)
No TRAP 768 ± 31 734 ± 24 1.0
WT TRAP 80 ± 5 0.4 ± 0.1 200
T30V TRAP 50 ± 4 46 ± 5 1.1
aB.subtilis strain, BYC1 (DmtrB trpE0-0lacZ) transformed with pVP5, or pVP5
containing either the WT or T30V mtrB gene. Cells were grown in the absence
or presence of 50 mg/ml tryptophan.
bb-Galactosidase activity is given in Miller Units.
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a similar mechanism as tryptophan binding, then we might
expect the mutant protein to be resistant to trypsin cleavage.
However, contrary to this prediction, the efﬁciency of trypsin
cleavage of T30V TRAP was comparable to that of apo-
TRAP (Figure 1). T30V TRAP was equally sensitive to try-
psin cleavage in the absence or presence of tryptophan,
which is consistent with earlier ﬁndings demonstrating that
this protein does not bind tryptophan (16,17). Hence the
decrease in accessibility of residue 31 to trypsin cleavage
seen with WT TRAP is not essential for RNA binding to
TRAP, at least in the case of T30V TRAP.
Other substitutions at position 30
Previous studies of TRAP with Ala and Val substitutions at
position 30 suggested that this residue plays a key role in
tryptophan-induced activation of TRAP (16). We further
examined the role of this residue in activation of TRAP by
introducing several other substitutions that altered the size
and/or the hydrogen bonding properties of the side chain of
residue 30. In each case we tested the tryptophan- and RNA-
binding activities of the resulting mutant protein (Table 2).
The mutant proteins that we examined can be divided into
four classes based on their RNA binding properties: (i) those
that do not bind RNA in either the absence or presence of
tryptophan; (ii) those similar to T30V, which bind RNA con-
stitutively and are not affected by the presence of tryptophan;
(iii) those similar to WT TRAP, which bind RNA in
a tryptophan-dependent manner and (iv) those that bind
RNA in the absence of tryptophan but their afﬁnity for RNA
is increased in the presence of tryptophan, which we call par-
tially constitutive. T30A TRAP is the only member of the ﬁrst
class of mutant proteins that do not bind RNA irrespective of
the absence or presence of tryptophan. Other than T30V, only
T30I TRAP displayed strictly constitutive RNA binding. T30I
bound RNA with similar afﬁnity as T30V TRAP and also




Figure 1. Trypsin cleavage of WT and mutant TRAP proteins. TRAP
proteins were digested with 5% trypsin either in the absence (lanes 1–4) or
presence (lanes 5–8) of tryptophan and samples were removed at various
times. Cleavage was monitored on 16% SDS–polyacrylamide gels that were
stained with GelCode Blue (Pierce). Bands were quantitated using
ImageQuant (Molecular Diagnostic) and the results were plotted as
percentage cleavage versus incubation time with trypsin.
Table 2. RNA and tryptophan binding affinities of WT and TRAP
mutants with substitutions at position 30
TRAP (GAGUU)11 RNA binding Kd (nM)
a Tryptophan
binding S0.5 (mM)
b +Tryptophan  Tryptophan
Wild Type 1.0 ± 0.5 NB
c 1.5 ± 0.2
T30A NB NB NB
T30V 144 ± 22 115 ± 16 NB
T30I 110 ± 10 177 ± 20 NB
T30S 1.0 ± 0.5 NB 2.0 ± 0.3
T30C
d 8.0 ± 0.1 NB 3.0 ± 0.1
T30L 158 ± 18 NB 1.4 ± 0.3
T30P 180 ± 30 NB 1.1 ± 0.3
T30D 230 ± 6 NB 3.3 ± 0.3
T30E 335 ± 5 NB 4.5 ± 0.2
T30N 70 ± 7 518 ± 70 4.5 ± 1.0
T30Q 200 ± 30 620 ± 50 3.4 ± 0.3
aKd values were determined in the absence or presence of 1 mM tryptophan.
The data represent averages of the results of at least two experiments each
performed in duplicate.
bS0.5 is the concentration of free tryptophan at which the concentration of
bound tryptophan reaches 50% of the saturation level.
cNB, no binding detected.
dAssays performed in the presence of DTT.
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dependent RNA binding with afﬁnities ranging from
Kd   1 nM (similar to WT TRAP) to over 300 nM
(Table 2). Of these, T30S and T30C showed the highest
afﬁnity for RNA. Like Thr in WT TRAP, both Ser and Cys
contain uncharged polar side-chains that can accept a hydro-
gen bond from the amino group of tryptophan, suggesting that
these are important properties for residue 30 in tryptophan-
mediated activation of TRAP. Several other proteins in this
group showed 160- to 330-fold lower afﬁnity for RNA than
WT TRAP. These include T30D (Kd ¼ 230 nM) and T30E
(Kd ¼ 335), which have side chains that can hydrogen bond
with the NH group of bound tryptophan but also introduce
a negative charge into the binding pocket. Two other mem-
bers of this group, T30P and T30L, do not have a polar
side chain, and thus cannot accept a hydrogen bond from
the amino group of tryptophan. Proline’s cyclic side chain
introduces conformational constraints on the protein back-
bone. Introduction of proline at residue 30 may alter the
structure of the tryptophan binding site in a manner that
allows tryptophan to bind to T30P TRAP in the absence of
this hydrogen bond, and activate the protein to bind RNA.
The most unusual member of this group is T30L TRAP.
Both leucine and valine have similar aliphatic side chains
with leucine’s being just one methyl group larger than vali-
ne’s, yet the T30V and T30L TRAP proteins display rather
different properties (Table 2). One difference between these
amino acids is that valine is b-branched, whereas leucine is
g-branched.
Because all the mutant proteins in this class bound trypto-
phan with afﬁnities no more than 3-fold lower than WT
TRAP (Table 2), the reduced afﬁnity for RNA seen in
some cases cannot be due to partial saturation with trypto-
phan under the conditions of the RNA binding assay (1 mM
L-tryptophan) but must be due to partial activation the
proteins.
In the last group, which we designate partially constitutive,
T30N or T30Q TRAP bound RNA in the absence of trypto-
phan (Kd ¼ 500–600 nM) but their afﬁnity for RNA was
enhanced 3- to 7-fold in the presence of tryptophan
(1 mM). Both proteins bound tryptophan with afﬁnity similar
to WT TRAP (S0.5 3–5 mM). Hence the reduced afﬁnity for
RNA that these proteins display in the presence of tryptophan
is not due to partial saturation of their tryptophan binding
sites. Both of these mutant TRAP proteins contain residues
at position 30 that are larger than Thr, and that have polar
uncharged side chains with amino groups.
Substitution of RNA binding residues in T30V TRAP
Previous studies demonstrated that, in general, T30V TRAP
recognizes similar features of the (G/U)AG repeats in RNA
as does tryptophan-activated WT TRAP (17). However,
from these studies it was not clear whether the same amino
acid residues on both proteins are involved in binding
RNA. For WT TRAP these residues are principally Glu36,
Lys37, Lys56 and Arg58 (10–12,28). As seen previously
(12), replacing any of these residues with an Ala residue
reduced the afﬁnity of WT TRAP for RNA from 26-fold to
over 400-fold while having only minor effects on tryptophan
binding (Table 3). To determine if these residues are
important for RNA binding in T30V TRAP, we examined
the effects of combining Ala substitutions at each of these
positions with the T30V substitution. Replacing Glu36,
Lys56 or Arg58, with Ala reduced the afﬁnity of T30V
TRAP for RNA (Table 3). With T30VK56A TRAP the effect
was 2.5-fold while the T30VR58A and T30VE36A doubly-
altered TRAPs showed no detectable RNA binding. Hence
these three residues play signiﬁcant roles in binding RNA
with both the WT and T30V proteins.
Substituting Lys37 with an Ala had different effects on
RNA binding to WT TRAP as compared to T30V TRAP
(Table 3). Several structures of TRAP–RNA complexes
show that the main-chain amino and carboxyl groups of
Lys37 hydrogen bond with the base of the A residue of
each GAG or UAG repeat (10,11). In addition, the aliphatic
portion of side-chain of Lys37 makes hydrophobic inter-
actions with the ﬁrst base of the repeat. Consistent with
these structural data, a series of substitutions at residue 37
showed that decreasing the length of the side chain resulted
in corresponding decreases in afﬁnity of the resulting mutant
proteins for RNA (10,12). In contrast, substituting Lys37 with
Ala in T30V TRAP had no signiﬁcant affect on the afﬁnity of
T30VK37A TRAP for (GAGUU)11 RNA as compared to
T30V TRAP (Table 3). Similar results were obtained when
comparing T30V and T30VK37A TRAP binding to an
RNA with U in the ﬁrst position of the repeats:
(UAGUU)11 RNA (Kd ¼ 136 and 115 nm, respectively).
These observations indicate that the aliphatic side chain of
Lys37 does not play the same role in T30V TRAP binding
to RNA that it does in WT TRAP. This difference may, at
least in part, explain the lower afﬁnity of T30V TRAP for
RNA as compared to tryptophan-activated WT TRAP.
Substitutions at residue 39 of T30V TRAP
The results above, comparing the role of Lys37 in WT and
T30V TRAP, suggest that these two proteins interact dif-
ferently with the ﬁrst residue of the (G/U)AG repeats. The
Table 3. Substitutions of RNA binding residues in WT and T30V TRAP
TRAP (GAGUU)11 RNA binding Kd (nM)
a Tryptophan
binding S0.5 (mM)
b +Tryptophan  Tryptophan
Wild-type 1.0 ± 0.5 NB
c 1.5 ± 0.2
K37A 130 ± 20 NB 6.8 ± 0.4
K56A 35 ± 4 NB 5.8 ± 2.0
R58A 26 ± 3 NB 2.0 ± 0.5
E36A 407 ± 42 NB 8.5 ± 1.1
D39A 0.25 ± 0.05 NB 2.7 ± 0.2
T30V 144 ± 22 115 ± 16 NB
T30VK37A 101 ± 25 92 ± 4 3.4 ± 1.1
T30VK56A 360 ± 24 NB 2.1 ± 0.2
T30VR58A NB NB 2.2 ± 0.4
T30VE36A NB NB 2.9 ± 0.3
T30VD39A 6 ± 1 7 ± 1 2.8 ± 0.1
T30VD39V 126 ± 6 127 ± 5 5.3 ± 0.5
aKd values were determined in the absence or presence of 1 mM tryptophan.
The data represent averages of results from at least two experiments,
each performed in duplicate.
bS0.5 is the concentration of free tryptophan at which the concentration of
bound tryptophan reaches 50% of the saturation level.
cNB, no binding detected.
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that the side chain of Asp39 forms a hydrogen bond with the
ﬁrst G or U of the triplet repeats of the bound RNA (10,11).
However we previously observed that replacing Asp39 with
Ala does not reduce the afﬁnity of TRAP for RNA (12)
(also see Table 3). To further examine the interaction of
T30V TRAP with the ﬁrst G or U of the repeats, we deter-
mined the effects of substituting Asp39 with an Ala residue.
The T30VD39A double mutant protein retained tryptophan-
independent RNA binding and showed a 24-fold increased
afﬁnity for (GAGUU)11 RNA as compared to T30V TRAP
(Table 3). Similar results were obtained for binding to
(UAGUU)11 RNA (data not shown). Hence, while substitut-
ing Asp39 with Ala has only a limited (4-fold) effect on
tryptophan-activated WT TRAP, this substitution signiﬁc-
antly (24-fold) increases the afﬁnity of T30V TRAP for RNA.
The Ala side chain is neutral and smaller than the negat-
ively charged side chain of Asp. To investigate the import-
ance of the size of the side chain at position 39 on the
RNA binding properties of T30V TRAP, we substituted Val
at this position, which is also neutral but is larger than Ala.
T30VD39V TRAP showed   20-fold lower afﬁnity for
(GAGUU)11 RNA than T30VD39A TRAP, resulting in sim-
ilar afﬁnity for this RNA as T30V TRAP; binding remained
tryptophan independent (Table 3). Thus a side chain that is
larger than Ala at position 39 interferes with the binding of
T30V TRAP to RNA.
Trypsin cleavage of T30VD39A TRAP
Prior studies demonstrated a correlation between tryptophan
activation of TRAP and protection from trypsin cleavage
after residue 31 (15). There are several possible explanations
for these observations. One possibility is that the bound
tryptophan directly hinders trypsin’s ability to cleave TRAP
after residue 31. Alternatively, tryptophan binding may
bring about a conformational change in TRAP that reduces
the susceptibility to trypsin; this change may, or may not
be, responsible for activating the protein to bind RNA. We
have shown that T30V TRAP binds RNA but is susceptible
to cleavage by trypsin (Figure 1). However, since this mutant
protein does not bind tryptophan it is not possible to test the
ﬁrst possibility using this protein. Moreover, since T30V
binds RNA with  100-fold lower afﬁnity than tryptophan-
activated WT TRAP, it is also possible that the conform-
ational change which protects residue 31 may only be
associated with the higher afﬁnity RNA binding seen with
WT TRAP. The T30VD39A double mutant protein provides
an opportunity to test both possibilities. This protein binds
RNA constitutively with high afﬁnity (Kd   6 nM) and also
binds tryptophan with similar afﬁnity as WT TRAP (Table 3).
Hence if the bound tryptophan directly protects residue 31
from trypsin then T30VD39A should be less sensitive to
cleavage in the presence of tryptophan than in its absence.
On the other hand, if protection of residue 31 reﬂects a con-
formational change required for high afﬁnity binding to RNA
then this protein might be resistant to trypsin cleavage in the
absence or presence of tryptophan. In contrast to both
predictions, we found that T30VD39A TRAP was cleaved
efﬁciently by trypsin both in the presence and absence of
tryptophan (Figure 1). This observation indicates that the
presence of tryptophan in the binding pocket is not sufﬁcient
to protect residue 31 from trypsin. Moreover, any conform-
ational changes that protect residue 31 are not essential
for high afﬁnity RNA binding (at least in the case of
T30VD39A TRAP). Hence the signiﬁcance of the protection
of residue 31 by tryptophan binding to WT TRAP remains
unclear.
Effects of substitutions of RNA binding residues on
tryptophan binding to T30V TRAP
Altering any of the residues in the RNA binding region of
T30V TRAP affected the tryptophan binding properties of
the resulting double mutant proteins. T30V TRAP does not
bind tryptophan (16,27), whereas all of these double mutant
proteins bound tryptophan with similar afﬁnity as WT
TRAP (Table 3). We addressed whether tryptophan binding
to these mutant proteins affects their RNA binding properties.
For T30VK37A, tryptophan binding had no appreciable
effect on the afﬁnity of the protein for RNA (Kd   100 nM
in the absence or presence of tryptophan). For T30VE36A
and T30VR58A TRAP, RNA binding was undetectable in
the absence or presence of tryptophan. However, since both
Glu36 and Arg58 are crucial residues for binding RNA
(replacing either of these resides with Ala severely affects
the interaction with WT TRAP to RNA (12) (Table 3), the
lack of RNA binding to T30VE36A and T30VR58A TRAP
may not be indicative of whether tryptophan binding has
any effect on the RNA binding region of these proteins.
For T30VK56A TRAP, the afﬁnity for RNA increased
from being undetectable in the absence of tryptophan to
a Kd of 360 nM in the its presence (Table 3). This protein
therefore provided an opportunity to further investigate why
changes in the RNA binding region affect tryptophan bind-
ing at a site   7.5 A ˚ away (there are over 10 A ˚ separating
the closest atoms of Lys56 and the bound tryptophan). Repla-
cing Lys56 with Ala both shortens the side chain and elimin-
ates its charge. We made several additional substitutions at
position 56 to examine the importance of both of these prop-
erties on tryptophan binding and activation of double mutant
proteins that also contain the T30V change (Table 4).
Table 4. Effect of substitutions at position 56 in T30V TRAP on tryptophan
and RNA binding properties
TRAP (GAGUU)11 RNA binding Kd (nM)
a Tryptophan
binding S0.5 (mM)
b +tryptophan  Tryptophan
Wild-type 1.0 ± 0.5 NB
c 1.5 ± 0.2
K56A 35 ± 4 NB 5.8 ± 2.0
T30V 144 ± 22 115 ± 16 NB
T30VK56A 360 ± 24 NB 2.0 ± 0.3
T30VK56V 98 ± 9 NB 1.3 ± 0.6
T30VK56L 93 ± 7 NB 4.6 ± 0.4
T30VK56M NB NB NB
T30VK56E NB NB NB
aKd values were determined in the absence or presence of 1 mM tryptophan.
The data represent averages of results from at least two experiments
each performed in duplicate.
bS0.5 is the concentration of free tryptophan at which the concentration of
bound tryptophan reaches 50% of the saturation level.
cNB, no binding detected.
2938 Nucleic Acids Research, 2006, Vol. 34, No. 10Changing residue 56 to Val or Leu, both of which have small
hydrophobic side chains, resulted in double mutant proteins
with similar tryptophan- and RNA-binding properties as the
T30VK56A mutant protein. However, increasing the size of
the side chain at position 56 by substituting with Met
eliminated tryptophan and RNA binding to T30VK56M.
Substituting Lys56 with Glu, which is negatively charged
and larger than Ala or Val, also eliminated tryptophan and
RNA binding (T30VK56E). Therefore the presence of
a small uncharged side chain at position 56 appears to be
important in allowing tryptophan to bind to and activate
the double mutant proteins that also contain the T30V
substitution.
DISCUSSION
Tryptophan-activation of TRAP to bind its target RNAs is
central to regulation of expression of the trp genes in
B.subtilis. However, the precise mechanism of tryptophan-
activation is not known, in part due to lack of a high resolu-
tion structure of apo-TRAP (i.e. TRAP in the absence of
bound tryptophan). In this study, we provide insight into
tryptophan-activation of TRAP by studying a mutant protein
(T30V) that binds RNA in the absence of bound tryptophan.
T30V TRAP recognizes similar RNA features as does WT
TRAP (17). Our results show that three of the four principal
RNA binding residues, Glu36, Lys56 and Arg58, are import-
ant for interacting with RNA in both WT and T30V TRAP
(Table 3). Lys37 is important for RNA binding to WT
TRAP but not for binding to T30V TRAP.
The side chain of Thr30 hydrogen bonds with the amino
group of the bound tryptophan (4). Our results with mutant
proteins bearing substitutions at position 30 indicate that as
long as the hydrogen bonding potential of this side chain is
maintained, TRAP can bind tryptophan and become activated
to bind RNA. Some mutant proteins bind RNA with lower
afﬁnity than WT TRAP even though they are fully saturated
with tryptophan (Table 2: T30D, T30E, T30N and T30Q).
The tryptophan analog indole-3-propionic acid lacks the
amino group of tryptophan and thus is unable to hydrogen
bond with Thr30. This analog does not bind to either WT
or T30V further demonstrating the importance of this interac-
tion (17). Together these observations provide further support
for the importance of residue 30 in both tryptophan binding
and activation of RNA binding as well as show that these
processes can be distinct from each other.
To date, mutants with substitutions at Thr30 are the only
examples of altered TRAP proteins that bind RNA con-
stitutively in the absence of bound tryptophan. These include
T30V and T30I, which suggests that constitutive binding is
the result of the presence of a intermediate sized hydrophobic
side chain at position 30 that cannot hydrogen bond with
tryptophan (16). However, T30L TRAP, with Leu at position
30, does not bind RNA constitutively but instead shows
tryptophan-dependent RNA binding. Hence, a hydrophobic
residue at position 30 alone is not sufﬁcient to activate
TRAP to bind RNA (and the ability of the side chain at res-
idue 30 to hydrogen bond is not essential for tryptophan bind-
ing or activation). While Val, Ile and Leu all have small
aliphatic side chains, only the Val and Ile side chains are
b-branched, suggesting this property may be important to
induce tryptophan-independent RNA binding. b-Branching
of the side chain restricts the conformations that the peptide
backbone can adopt due to steric considerations (29,30).
Hence, the presence of the b-branched Val or Ile residues
at position 30 may bring about changes in the protein back-
bone that activate these mutant proteins to bind RNA.
Perhaps one reason that Thr30 plays a key role in activa-
tion of TRAP is that it is the only residue in the protein
that interacts with both the bound tryptophan and bound
RNA. The side chain hydroxyl of Thr30 hydrogen bonds
with the amino group of the bound tryptophan. In the com-
plex with (GAGAU)11, the main chain carbonyl oxygen of
Thr30 hydrogen bonds with the NH2 of the third G of each
repeat (Figure 2), and makes a hydrogen bond to the
20 sugar hydroxyl of the preceding A via a bridging water
molecule (11). Therefore, changes at residue 30 have the
potential to directly affect both the tryptophan and RNA bind-
ing properties of TRAP.
NMR studies have demonstrated that tryptophan binding
reduces the ﬂexibility of TRAP (15). These authors also
showed that tryptophan binding to WT TRAP results in
changes in the vicinity of residue 31 that reduce accessibility
of this residue to trypsin. However, it was not clear whether
these changes affecting residue 31 are directly tied to activa-
tion of TRAP to bind RNA. Given that we have shown that
Thr30 plays a key role in activation of TRAP, it was reason-
able to propose that these changes in the protein in the vicin-
ity of residue 31 might be associated with activation.
Figure 2. Ribbon diagram of TRAP complexed with RNA. One complete
subunit (light blue) and parts of the two adjacent subunits (green and brown)
in TRAP are shown. The loop formed from residues 25–33 and the adjacent
b-strand (residues 34–38) proposed to be key in tryptophan-mediated
activation of RNA binding are highlighted in dark blue. The b-strands are
depicted as arrows and the bound tryptophans as ball and stick models. The
side chains of several key amino acids are shown in either ball and stick
models on the complete subunit. RNA binding residues are in red, Thr30 is in
magenta. The RNA is shown as golden stick diagrams and the bases from one
GAGAU repeat are labeled. The hydrogen bonds between Thr30 and the
bound tryptophan as well as to the third G are shown as dashed lines.
Nucleic Acids Research, 2006, Vol. 34, No. 10 2939However our results with several mutant proteins do not sup-
port this hypothesis. Both T30V and T30VD39A TRAP,
which bind RNA constitutively, are susceptible to cleavage
by trypsin. Hence the changes that protect residue 31 are
not essential for RNA binding, at least not with these mutant
proteins. Moreover, comparing the properties of WT, T30V,
T30VD39A TRAP shows that there is no correlation between
the afﬁnities of these proteins for RNA and their sensitivity to
trypsin cleavage. In addition, T30VD39A TRAP binds trypto-
phan (with no effect on the afﬁnity for RNA) yet this protein
is cleaved by trypsin equally well in the absence or presence
of tryptophan. Together these observations show that the
changes in the vicinity of residue 31 which protect TRAP
from trypsin cleavage are not required for TRAP to bind
RNA. It is also possible that the changes at residue 31 reﬂect
an alteration in the protein required for tryptophan-activation
of WT TRAP, and the mutant proteins are activated to bind
RNA by a different means. However our data showing that
T30V TRAP recognizes similar features of the RNA and
uses most of the same residues in the protein to bind to it,
suggests that the mutant proteins are activated by at least
a similar mechanism as tryptophan binding to WT TRAP.
Our results suggest that although WT and T30V TRAP
recognize similar features of RNA (17), these two proteins
interact differently with the ﬁrst base of each (G/U)AG
repeat. Several crystal structures of TRAP complexed with
RNA show that both Lys37 and Asp39 interact with the
ﬁrst G or U of the repeats (10,11) (Figure 2). We found
that substitutions at Lys37 and Asp39 have different effects
on WT and T30V TRAP. Consistent with the structural
data, substitution of Lys37 with Ala in WT TRAP is deleteri-
ous to binding RNA (Table 3). In contrast, this change has no
signiﬁcant effect on the RNA binding afﬁnity of the T30V
protein. Conversely, changing Asp39 to Ala has no effect
on WT TRAP binding to RNA yet this change increases afﬁn-
ity for RNA with T30V TRAP. The results with Asp39 are
particularly interesting because several crystal structures
indicate that this residue forms a hydrogen bond with the
ﬁrst G or U in the RNA repeats, yet we can ﬁnd no evidence
that this interaction contributes to the stability of the complex
of WT TRAP with RNA [Table 3; (12)]. In T30V TRAP it
seems that the side chain of residue 39 interferes with RNA
binding when it is larger than the methyl group of Ala. These
differences between T30V and WT TRAP were observed
regardless of whether there was a G or a U in the ﬁrst position
of the RNA repeats. Together these observations suggest that
the orientations of Lys37 and Asp39 are different between
complexes of T30V and tryptophan-activated WT TRAP
with RNA. These differences may, at least in part explain
the lower afﬁnity of T30V TRAP than WT TRAP for RNA.
Altering residues in the RNA binding region of T30V
TRAP to Ala had the unexpected effect of restoring trypto-
phan binding activity to this protein, which otherwise does
not bind tryptophan (Table 3). Further investigation of this
ﬁnding by making changes at Lys56 showed that residues
with smaller side chains at position 56 allow the mutant pro-
teins to bind tryptophan, whereas those with larger side
chains do not (Table 4). There are two possible explanations
for these observations. First, the side chain of residue 56
could directly interfere with tryptophan accessing its binding
site. Alternatively, changes at residue 56 could affect the
conformation of the protein and thereby inﬂuence its trypto-
phan binding properties indirectly. The structure of TRAP
complexed with RNA shows that Lys56 is over 10 A ˚ from
the bound tryptophan (4). This would seem to argue against
the simple steric hindrance model. However, the location of
Lys56 in apo-TRAP is not known. Several observations sug-
gest there must be a signiﬁcant difference in the arrangement
of the tryptophan binding site in apo-TRAP as compared to
the complex with tryptophan, which could also be the case
in T30V TRAP. For example, in the WT TRAP–tryptophan
complex the bound tryptophan is almost completely buried
in the binding pocket (4). Hence for tryptophan to enter the
binding site, it must be in a more open conformation in
apo-TRAP. Consistent with this proposal, NMR studies
show that the tryptophan binding region of the protein is dis-
ordered in the absence of tryptophan and then becomes
ordered when tryptophan binds (15). Thus with T30V
TRAP it is possible that a large side chain at position
56 might directly create steric hindrance to tryptophan
binding in its binding pocket.
In addition to TRAP-mediated regulation of the trp genes
in response to changes in intracellular free tryptophan,
B.subtilis also regulates expression of these genes in response
to accumulation of uncharged tRNA
Trp (31–33). Accumula-
tion of uncharged tRNA
Trp leads to expression of the anti-
TRAP (AT) protein, which antagonizes TRAP activity, thus
increasing expression of the trp genes (33,34). AT does not
bind to apo-TRAP but speciﬁcally binds to tryptophan-
activated TRAP and prevents it from binding to RNA
(34,35). Studies of AT binding to mutant TRAP proteins sug-
gest that AT recognizes similar features of TRAP that are
essential for binding RNA, including Lys37, Lys56 and
Arg58 (35). Preliminary studies indicate that AT does not
bind to T30V TRAP in vitro (Y. Chen, D. Paul and
P. Gollnick unpublished data). These observations suggest
that while T30V TRAP functions similarly as tryptophan-
activated WT TRAP, the RNA binding surfaces of the
two proteins are not identical. Our studies suggest that
Lys37 may be positioned differently between the two
proteins, which may explain why T30V TRAP is not recog-
nized by AT.
One of the most extensively studied proteins that shows
ligand induced activation of nucleic acid binding is the Trp
repressor of E.coli (36). Upon binding two molecules of L-
tryptophan, the Trp repressor dimer binds to its operator
DNA and blocks RNA polymerase from binding to the pro-
moter. Each monomer is composed of six a helices, two of
which form a helix–turn–helix (HTH) motif that contains
the amino acid residues that interact directly with the DNA
(37–39). Tryptophan binding induces the HTH substructures
from each subunit to move apart so that they can ﬁt into the
two successive major grooves of the DNA, which is essential
for operator speciﬁc recognition (40). In addition, tryptophan
binding also stabilizes the HTH substructures, which are
more ﬂexible in the absence of tryptophan (37,41). Therefore,
in part, tryptophan binding activates the Trp repressor to bind
operator DNA by a similar mechanism involving changes
in protein ﬂexibility that has been proposed for TRAP activa-
tion (15).
Our results suggest that changes in the RNA binding and
tryptophan binding regions of TRAP inﬂuence one another.
2940 Nucleic Acids Research, 2006, Vol. 34, No. 10These changes may reﬂect the pathway that normally conveys
changes when tryptophan binds to activate RNA binding. One
possible means for this transfer of information between the
two binding regions would be via the residues that most
directly connect the two binding sites. According to this
model, tryptophan binding would introduce changes in resi-
dues in its binding site—particularly Thr30—and these
changes would be transmitted to the RNA binding site via
residues most directly adjacent along the polypeptide back-
bone to one or more residues that contact the RNA. Two
key residues that contact the RNA, Glu36 and Lys37, are
directly linked to Thr30 by a portion of the loop made up
of residues 25–33 and by the b-strand composed of residues
34 to 38 (Indicated in dark blue on Figure 2). The hypothesis
that this means of communication is important in the
activation mechanism is supported by results from previous
mutagenesis studies (12). These studies showed that Ala
substitutions in several of these connecting residues, includ-
ing Lys31 and His33, interfere with TRAP-mediated regula-
tion of the trp operon in vivo even though neither residue
directly interacts with either tryptophan or RNA. Determining
the tryptophan and RNA binding properties of these mutant
proteins may provide additional insight into the role of
these residues in the activation mechanism of TRAP.
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